Gyno-Pevaryl

Gyno‑Pevaryl is a vaginal formulation that contains the antifungal agent econazole nitrate. It belongs to the imidazole class of antifungal medicines and is marketed in the European Union. The product is intended for local treatment of fungal infections of the female genital tract. Econazole nitrate works by disrupting fungal cell membrane synthesis, providing a targeted approach to managing vulvovaginal candidiasis and alleviating associated symptoms in affected women.

Gyno‑Pevaryl is indicated for the treatment of vulvovaginal candidiasis, a common yeast infection of the vagina and vulva.

- Local therapy of acute vulvovaginal candidiasis caused by Candida species. - Adjunctive treatment for recurrent vulvovaginal yeast infections when prescribed by a healthcare professional. - Management of mild to moderate fungal infections of the vaginal mucosa. - Use in adult women for symptomatic relief of itching, burning, and discharge associated with candidal infection. - Application as directed for prevention of infection recurrence after successful treatment.

The safety profile of Gyno‑Pevaryl reflects the typical adverse events reported with topical imidazole antifungals.

Common: - Mild vaginal irritation or burning sensation. - Itching or mild pruritus at the application site. - Transient vaginal discharge that may be watery or whitish. - Local dryness or feeling of tightness. - Mild discomfort during intercourse.

Serious: - Allergic contact dermatitis presenting as redness, swelling, or rash. - Severe vaginal ulceration or ulcerative lesions. - Persistent or worsening symptoms despite therapy. - Signs of systemic hypersensitivity such as fever, hives, or swelling of the face.

Before using Gyno‑Pevaryl, certain precautions should be considered to ensure safe and effective treatment.

- Confirm diagnosis of vulvovaginal candidiasis before initiating therapy. - Avoid use if you have a known hypersensitivity to econazole nitrate or other imidazole antifungals. - Do not apply the product on inflamed, ulcerated, or damaged vaginal tissue without medical advice. - Pregnancy and breastfeeding status should be discussed with a healthcare provider, as safety data are limited. - If symptoms persist beyond the recommended treatment period, seek further medical evaluation. - Do not use concomitantly with other intravaginal medications unless directed by a clinician.

Gyno‑Pevaryl may interact with other substances applied vaginally or systemic medications that affect fungal flora.

Avoid: - Concurrent use of other intravaginal antifungal agents without professional guidance. - Application of vaginal spermicides or douches that could alter drug absorption.

Use with caution: - Systemic azole antifungals (e.g., fluconazole) as combined therapy may increase risk of adverse effects. - Topical corticosteroids in the vagina, which could mask irritation. - Hormonal contraceptives administered vaginally, though no direct interaction is established, monitor for efficacy.